Effect of L-Carnitine Supplementation in Preterm Neonates
Recruiting
N/A
Interventional Study
Respiratory Distress Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 1 Hour – 24 Hours
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 160 (estimated)
- Sponsor
- Muhammad Aamir Latif · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The current study is planned to see the effect of L-carnitine supplementation in preterm neonates suffering from RDS among the local population, as there is no such evidence available for the local population and there are conflicting statistics regarding the discharge rate of these neonates.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Preterm neonates
* Either gender
* With RDS
* Admitted to the neonatal intensive care unit (NICU) within 24 hours of birth .
Exclusion Criteria:
* Neonates with gastrointestinal tract (GIT) anomalies
* With confirmed or suspected sepsis at the time of enrollment
* Neonates w…
Contacts